| 1 | PYGO2 |
| Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. | |
| Chen J, Luo Q, Yuan Y, Huang X, Cai W, Li C, Wei T, Zhang L, Yang M, Liu Q, Ye G, Dai X, Li B. | |
| Mol Cell Biol 30(24):5621-35. Epub 2010 Oct 11. 2010 | |
| 2 | ELF1, PYGO2 |
| Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1. | |
| Andrews PG, Kennedy MW, Popadiuk CM, Kao KR. | |
| Mol Cancer Res 6(2):259-66.PMID: 18314487 2008 | |
| 3 | PYGO1, PYGO2 |
| Pygopus residues required for its binding to Legless are critical for transcription and development. | |
| Townsley FM, Thompson B, Bienz M. | |
| J Biol Chem 279(7):5177-83. Epub 2003 Nov 11. 2004 | |
| 4 | BCL9, PYGO1, PYGO2 |
| Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. | |
| Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K. | |
| Cell 109(1):47-60. 2002 | |